Transferon en el 2020
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. VER...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 20 Septiembre 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 6 de septiembre de 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS